Stock-Based Compensation (Details) - USD ($)	9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Sep. 29, 2021	Jul. 31, 2021
Stock-Based Compensation (Details) [Line Items]
Expiration date	Jul. 31, 2025
Stock issued (in Shares)	1,150,000		150,000
Stock option exercise price (in Dollars per share)	$ 0.11
Stock based compensation, description		●7,608,820 common shares to various employees as part of the Company’s Non-Standardized profit-sharing plan contribution. The Company recognized stock-based compensation expense of $247,287 equivalent to the value of the shares calculated based on the share’s closing price at the grant dates.   ●250,000 common shares to a former member of the Management team for services in lieu of cash compensation. The Company recognized stock-based compensation expense of approximately $17,500 equivalent to the value of the shares calculated based on the share’s closing price at the grant dates.    ●500,000 options to purchase common shares to one of our members of the Board of Directors with an exercise price of $0.1475 per share and a term of 5 years. At issuance, 166,666 of the options vested and 333,334 of the options will vest equally over a period of two years. At the time of issuance, the options had a fair market value of $52,531.   ●3,730,000 options to purchase common shares to various employees with an exercise price of $0.04 per share and a term of 5 years. At issuance, 33,333 of the options vested, 66,667 of the options will vest equally over a period of two years, and 3,630,000 of the options will vest equally over a period of three years. The options have a fair market value of $214,812.
Recognized stock-based compensation expense	$ 74,466	$ 109,685
Unamortized compensation cost	$ 125,653	$ 220,861
Stock options exercisable shares (in Shares)	7,153,530			6,091,863
Stock options exercisable amount	$ 44,673			$ 91,978
2015 Equity Compensation Plan [Member]
Stock-Based Compensation (Details) [Line Items]
Stock options authorizes to grant (in Shares)	7,500,000
Various Employees [Member]
Stock-Based Compensation (Details) [Line Items]
Closing stock price, description	The aggregate intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) of the 9,230,000 and 9,230,000 stock options outstanding as of April 30, 2022, and July 31, 2021, was $141,367 and $392,891, respectively.